Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004).

Tsuchiya-Kawano, Yuko; Shiraishi, Yoshimasa; Kiyomi, Fumiaki; Okamoto, Isamu

Tsuchiya-Kawano, Yuko; Shiraishi, Yoshimasa; Kiyomi, Fumiaki; Okamoto, Isamu.

Afiliación

Tsuchiya-Kawano Y; Department of Respiratory Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
Shiraishi Y; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kiyomi F; Statistics and Data Center, Clinical Research Support Center Kyushu, Fukuoka, Japan.
Okamoto I; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Cancer Manag Res ; 13: 8489-8493, 2021.

Article en En | MEDLINE | ID: mdl-34795528

Palabras clave

NSCLC; brain metastases; clinical trial; intracranial response rate; nivolumab plus ipilimumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Cancer Manag Res Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google